Wellesley College
12Patents
2Active
12Granted
35Portfolio score
Filing activity: Jan 8, 1987 → Mar 14, 2014
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4766069A | Recombinant DNA which codes for interleukin-1 B | Emerging Cross-Sectional Technologies | 45 | Expired |
| US5510462A | IL-1.beta.protein precursor | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5681933A | Antibodies to IL-1.beta. | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5077219A | Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins | Chemistry; Metallurgy | 24 | Expired |
| US5001057A | Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins | Emerging Cross-Sectional Technologies | 21 | Expired |
| US4923807A | Arg-Serpin human plasminogen activator inhibitor designated PAI-2 | Human Necessities | 19 | Expired |
| US6307978A | System and method for parallel error diffusion dithering | Electricity | 19 | Expired |
| US5985657A | Recombinant DNA which codes for interleukin-1 | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5849999A | Transgenic non-human mice expressing Flag-APP-C100 protein develop alzheimer's disease brain morphology and behavior | Chemistry; Metallurgy | 3 | Expired |
| US5998578A | Biologically active fragments of IL-1.beta. | Human Necessities | 3 | Expired |
| US9388155B1 | Coumarin derivatives for cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US9403791B1 | Coumarin derivatives for cancer therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.